CYPH
NASDAQ · Biotechnology
Cypherpunk Technologies Inc
$0.61
-0.02 (-3.57%)
Open$0.62
Previous Close$0.64
Day High$0.65
Day Low$0.61
52W High$3.70
52W Low$0.23
Volume—
Avg Volume4.11M
Market Cap67.81M
P/E Ratio—
EPS$-0.69
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+6,223.7% upside
Current
$0.61
$0.61
Target
$38.72
$38.72
$25.17
$38.72 avg
$55.57
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 17.60M | 17.28M | 16.86M |
| Net Income | 2.07M | 2.55M | 2.09M |
| Profit Margin | 11.8% | 14.8% | 12.4% |
| EBITDA | 4.18M | 3.81M | 3.82M |
| Free Cash Flow | 1.52M | 982.4K | 1.03M |
| Rev Growth | +11.2% | +9.6% | +9.9% |
| Debt/Equity | 0.55 | 0.54 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |